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675Intravascular Frequency-Domain Optical Coherence Tomography Assessment of
Carotid Artery Disease in Symptomatic and Asymptomatic PatientsObjectives The goal of this study was to investigate carotid plaque characteristics in symptomatic versus asymptomatic patients
with the use of nonocclusive optical coherence tomography (OCT).
Background The identiﬁcation of asymptomatic patients with carotid disease who are at risk of stroke remains a challenge. There is
an increasing awareness that plaque characteristics may best risk-stratify this population. We hypothesized that OCT, a new high-
resolution (w10 mm) imaging modality, might be useful for the identiﬁcation of low-risk versus high-risk carotid plaque features
and help us to understand the relationship between carotid diameter stenosis and plaque morphology to ischemic stroke.
Methods Fifty-three patients undergoing diagnostic carotid angiography were studied with OCT. Data analysis was carried out by
imaging experts who were unaware of the clinical characteristics of the study population.
Results Plaque with American Heart Association type VI complicated features was more common in symptomatic than
asymptomatic patients (74.1% vs. 36.4%, p ¼ 0.02). This was largely driven by differences in the incidence of thin-cap ﬁbroatheroma
with rupture (40.7% vs. 13.6%, p ¼ 0.056) and thrombus (67.7% vs. 36.4%, p ¼ 0.034). Conversely, non–type VI plaques were more
common in asymptomatic than symptomatic patients (63.6% vs. 25.9%, p ¼ 0.02). No association between the degree of stenosis
and plaque morphology was identiﬁed.
Conclusions This retrospective analysis of carotid OCT data supports the hypothesis that the evaluation of carotid plaque
characteristics with this high-resolution imaging technique has the potential to alter the understanding and treatment of carotid
artery disease. (J Am Coll Cardiol Intv 2014;7:674–84) ª 2014 by the American College of Cardiology FoundationStroke is the fourth leading cause of death and a leading
cause of disability in the United States. Carotid atheroscle-
rosis is implicated as the culprit in many of these cases, and
nearly two-thirds of these strokes occur in patients who were
previously asymptomatic (1,2). The identiﬁcation of patients
with asymptomatic disease who are at risk of stroke remains
challenging as there is an increasing awareness that the de-
gree of carotid stenosis is a poor predictor of stroke risk (3).
Although some studies indicate that, with modern medical
management, the outlook of asymptomatic carotid artery
disease has improved substantially (4) since the publication
of the North American (5) and European asymptomatic
trials (6), over 370,000 carotid artery revascularization pro-
cedures were carried out on asymptomatic patients in the
United States between 2005 and 2007 (7). These data pointSee page 685out the need for a revised paradigm to dictate indications
for revascularization on the basis of a better understanding of
stroke risk. Several studies have suggested that this stroke
risk may be best predicted by plaque characteristics in these
asymptomatic lesions (3,8–11).
Although the potential value of magnetic resonance (MR)
(11) and multidetector computed tomography imaging (8),as well as virtual histology intravascular ultrasound (12) to
assess these plaque characteristics has been reported in
small studies, current consensus guidelines cite only the
degree of stenosis as an indication for carotid revasculari-
zation (13).
This group recently described a pilot experience with the
use of nonocclusive optical coherence tomography (OCT) to
assess atherosclerotic plaque in human carotid arteries (14).
This newer light-based modality delivers resolution to 10 to
15 mm, giving it the highest imaging resolution of any
currently available vascular imaging technique. In fact, a
body of data obtained primarily in the coronary vasculature,
with extensive histopathological validation, documents the
utility of OCT not only in eliminating the angiographic
pitfalls of stenosis determination imposed by plaque eccen-
tricity (15,16) but also in the accurate identiﬁcation of pla-
que components such as lipid, calcium, and ﬁbrous tissue
(17). In addition, OCT makes it possible to directly visualize
and quantify thin-cap ﬁbroatheroma (TCFA), intraluminal
thrombus, calciﬁed nodules, and vascular inﬂammation (18–
24). These important features of American Heart Associa-
tion (AHA) type VI complicated, high-risk or vulnerable
plaque (25), heretofore largely invisible by other imaging
modalities due to their lower resolution, are readily identiﬁed
and quantiﬁed by the micron-scale resolution of OCT.
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676We hypothesized that the unprecedented in vivo resolu-
tion of OCT would not only allow a comparative insight
into the accuracy of the currently prescribed NASCET
(North American Symptomatic Carotid Endarterectomy
Trial) measurements of carotid stenosis but also provide
insights into morphological differences between symptom-
atic and asymptomatic plaques and their relationship to
carotid artery stenosis. Accordingly, we report the results of
OCT-derived luminal quantiﬁcation and morphological
plaque assessment in patients with and without recent
neurological events who underwent ad hoc nonocclusive
carotid OCT study at the time of diagnostic carotid
angiography.
Methods
Study design, patient selection, and in-hospital outcomes.
Fifty-four nonconsecutive patients coming to the Baptist
Heart and Vascular Institute, Lexington, Kentucky, forAbbreviations
and Acronyms
AHA = American Heart
Association
CI = conﬁdence interval
DSA = digital subtraction
angiography
MR = magnetic resonance
OCT = optical coherence
tomography
OR = odds ratio
TCFA = thin-cap
ﬁbroatheromaelective carotid angiography
between September 2010 and
May 2012 underwent ad hoc
OCT study. All patients gave
informed consent for the pro-
cedures performed, and a retro-
spective review of cases was
approved by the Baptist Hospi-
tal Institutional Review Board.
All OCT studies were carried
out to empirically facilitate clin-
ical management. Indications
included equivocal stenosis by
digital subtraction angiography
(DSA), clariﬁcation of DSAﬁndings, clariﬁcation of discordant DSA versus noninvasive
data, and the evaluation of presumed thromboembolic
stroke without clear etiology.
We separated the patients into 2 groups on the basis of
the presence or absence of previous symptoms (i.e., symp-
tomatic and asymptomatic groups). The symptomatic group
was deﬁned by a documented history of transient ischemic
attack, amaurosis fugax, or stroke in the vascular territory
supplied by the suspect carotid artery within the 6 months
preceding the examination. In-hospital occurrence of
myocardial infarction, death, new onset of stroke, transient
ischemic attack, and contrast-induced nephropathy were
recorded.
Quantitative vascular angiography analysis. NASCET
criteria for the calculation of the percent of diameter stenosis
were applied using quantitative analysis (Siemens, Munich,
Germany) by a single operator (C.A.G.) and reviewed by
a second operator (M.R.J.) before blinded OCT core labo-
ratory analysis. Angiographic and OCT analysis used cor-
egistration on the basis of an anatomic landmark (i.e.,carotid artery bifurcation) to ensure that measurements were
made at identical sites.
OCT imaging acquisition protocol. Before the OCT imaging
procedure, all patients underwent systemic anticoagulation
with unfractionated heparin to achieve a target activated
clotting time of 250 s. 7-F sheaths were used to facilitate
OCT catheter placement. Distal embolic protection (NAV-
6 Filterwire, Abbott Vascular, Redwood City, California)
was used in selected cases at the operator’s discretion. In the
other cases, the OCT catheter was advanced over a 0.014-
inch Transcend wire (Target Therapeutics, Fremont, Cali-
fornia). In each case, the delivered guidewires were used to
advance a 2.7-F Dragonﬂy imaging catheter (St. Jude
Medical, St. Paul, Minnesota) into the carotid artery under
study. Images were calibrated by adjustment of the Z-offset
and automated pullbacks covering 54 mm of the vessel
at 20 mm/s were then obtained (26). During image acqui-
sition, blood was displaced by hand injection of undiluted
contrast (25 ml of iodixanol 320 over a 5-s period using
a 30-ml syringe) in 46 patients or hand injection of a
heparinized saline solution (50 ml over a 5-s period using a
60-ml syringe) in the remaining 7 patients. Data were
acquired and digitally stored using commercially available
OCT systems (C7-XR or Ilumien Imaging System, St. Jude
Medical, St. Paul, Minnesota). Patient selection and
immediate treatment using online images were under the
auspices of an interventional cardiologist with coronary
OCT experience (M.R.J.), an interventional neuroradiolo-
gist (C.A.G.), and endovascular-trained neurosurgeons
(W.H.B., C.N.R.).
OCT imaging analysis. Anonymous patient data and ofﬂine
images were subsequently analyzed by 2 experienced OCT
readers (G.F.A. and Y.F.) blinded to patient and procedural
characteristics and reviewed by 2 other analysts (H.G.B. and
M.A.C.) in the Cardiovascular Imaging Core Laboratory,
Harrington Heart and Vascular Institute, University
Hospitals, Case Medical Center, Cleveland, Ohio. OCT
analyses were performed using dedicated software with an
automated contour-detection algorithm (Off-line Review
Software, version C.0.2; St. Jude Medical).
All cross-sectional images (frames) of the internal carotid
artery as well as the carotid bifurcation were initially
screened for quality assessment and were considered non-
analyzable if any portion of the image was out of the screen,
demonstrated fold-over artifact, or if the presence of intra-
luminal blood impaired the assessment of a continuous arc of
at least 270 (27,28). Before analysis was carried out, manual
OCT system calibration (Z-offset) was performed along the
entire pullback. Qualitative and quantitative measurements
of lumen areas and diameters were performed in every frame
(i.e., every 0.2 mm). The diseased segment (lesion location)
was identiﬁed, and the distal reference was deﬁned as the
most normal-appearing segment distal to the lesion shoul-
ders by OCT. The percent of diameter stenosis was
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677calculated on the basis of OCT-derived NASCET criteria,
as follows: distal reference lumen diameter minimal lumen
diameter/distal reference lumen diameter  100.
Observed plaque characteristics are shown in Figure 1. On
the basis of previously published pathological and noninva-
sive imaging data, we evaluated plaque for complicated
(AHA type VI) features known to be associated with adverse
clinical sequelae including the following: 1) ruptured TCFA;
2) intraluminal thrombus; and 3) ruptured calciﬁed nodule.
The deﬁnition of TCFA has been previously described (20).
We deﬁned thrombus as any mass protruding into the
lumen, with an irregular surface and a sharp intensity gap
between the mass and surrounding tissue (21). A ruptured
calciﬁed nodule was deﬁned as an irregular, protruding
calciﬁcation with irregular luminal surface and disrupted
ﬁbrous cap (22,24). We also captured the presence of
macrophage inﬁltration in the ﬁbrous cap (23) as well as the
presence of ﬁbrotic and calciﬁed plaques (18,19). Impor-
tantly, >1 featured could be identiﬁed in the same plaque.
Although a common feature found in unstable carotid
plaques with MR imaging, intraplaque hemorrhage (29)
was not captured in our analysis as both red blood cells and
lipid attenuate light substantially, making it difﬁcultFigure 1. Optical Coherence Tomography–Derived Plaque Characteristics
(A) Red thrombus (red arrowhead). (B) White thrombus (white arrowhead). (C) Ca
(red arrowhead). (D) Ruptured thin-cap ﬁbroatheroma (white arrow) with associat
plaque (calcium indicated by white asterisk).to properly differentiate intraplaque hemorrhage from a lipid
pool by OCT assessment.
To determine the reproducibility of OCT qualitative
assessments, data were analyzed by 2 independent analysts
and repeated 2 months after initial analysis.
Statistical analysis. Simple descriptive statistics were ob-
tained for patients’ demographic and baseline clinical char-
acteristics. Categorical data for the 2 groups were compared
using either chi-square analysis or the Fisher exact test where
appropriate. For continuous variables found to be non-
normal by the Kolmogorv-Smirnoff test, nonparametric
tests were used for comparison between groups. Interob-
server and intraobserver reliability was assessed using
Cohen’s statistic (30). Logistic regression analysis was con-
ducted on the dichotomous symptomatic outcome variable
with individually selected variables tested for predictive
capability. Statistically signiﬁcant odds ratios were used as
measures of meaningful prediction. The agreement between
OCT and angiography in the determination of stenosis
diameter was examined by a Bland-Altman plot.
Throughout the analysis, a 2-tailed level of 0.05 was
used as the threshold for determining statistical signiﬁcance.
p values were not adjusted for the various statistical testslciﬁed nodule (inset) with associated red thrombus overlying plaque rupture
ed red thrombus (red arrowheads). (E) Fibrotic plaque. (F) Fibrocalciﬁed
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678conducted. All statistical tests were conducted using SAS
software, version 9.2 (SAS Institute, Inc., Cary, North
Carolina).
Results
Patient characteristics and OCT procedures. A total of 54
patients were included. OCT imaging was conducted un-
eventfully in 53 patients (aborted in 1 patient before
OCT catheter delivery due to a small nonobstructive and
self-limited guiding catheter–related dissection). Data were
lost due to technical issues in electronic data storage for
1 patient, and suboptimal quality images precluded image
interpretation in 3 patients. Interpretable images were
obtained for 49 patients (93% of OCT frames were analyz-
able). The 2 reasons for nonanalyzable frames were out-of-
screen images (6.2%) and the presence of residual blood
impairing proper assessment (4.3%). Baseline patient char-
acteristics are shown in (Table 1). In symptomatic patients,
the mean time from the qualifying event to OCT study was
29 days (range 1 to 175 days). Symptomatic status appears
unrelated to sex, age, or outlined clinical characteristics
except to note that symptomatic patients were less likely to
have a history of coronary artery disease. Symptomatic
patients were also less likely to be taking a statin or a thieno-
pyridine, whereas no difference in aspirin use was observed.
Geometric carotid analysis. The median stenosis diameter
by angiography was more severe in asymptomatic compared
with symptomatic patients (67% [Q1 ¼ 58%, Q3 ¼ 74%]
vs. 39% [0%, 69%], respectively, p ¼ 0.004), preserving the
same trend by OCT stenosis diameter (66% [48%, 77%] vs.
42% [0%, 65%], p ¼ 0.098). There was good correlation
(r ¼ 0.93, p < 0.001) and agreement (Fig. 2) between
stenosis diameter measurements derived by angiography andTable 1. Patient Demographic and Clinical Data
Asymptomatic
(n ¼ 22)
Symptomatic
(n ¼ 27) p Value
Age, yrs 67 (11) 66 (18) 0.90
Male 13 (59.1) 20 (74.1) 0.27
Clinical features
Hypertension 21 (95.5) 21 (77.8) 0.11
Dyslipidemia 19 (86.4) 22 (81.5) 0.72
Diabetes 8 (36.4) 9 (33.3) 0.82
Smoker 7 (31.8) 11 (40.7) 0.52
Atrial ﬁbrillation 2 (9.1) 0 (0) 0.20
Coronary heart disease 16 (72.7) 5 (18.5) <0.001
Previous carotid intervention 6 (27.3) 3 (11.1) 0.11
Medications
Statin 19 (86.4) 12 (44.4) 0.003
Aspirin 19 (86.4) 20 (74.1) 0.48
Plavix (clopidogrel) 13 (59.1) 6 (22.2) 0.008
Values shown are median (IQR) for age, n (%) for all other variables.OCT. Nonetheless, using current AHA criteria for revas-
cularization (stenosis diameter: asymptomatic, 60%;
symptomatic, 50%), 29% of the study group who would
be treated on the basis of angiography would have their
treatment deferred on the basis of OCT-derived stenosis
diameter assessment. Conversely, 11% of patients who
would not qualify for revascularization on the basis of
angiographic information would be treated using OCT-
derived criteria (Fig. 3). Even after exclusion of the 14
symptomatic patients who were studied because of the
known absence of severe carotid stenosis on noninvasive
studies, the lack of correlation between symptoms and
stenosis diameter persisted (p ¼ 0.33 after elimination; p ¼
0.10 for all patients). Furthermore, there were no observed
associations between the severity of OCT-derived stenosis
diameter and complicated plaque features (chi-square ¼
0.3403; p ¼ 0.56) (Figs. 4 and 5).
Plaque characteristics. We demonstrated very low intra-
(Cohen’s kappa ¼ 0.96, p < 0.001) and interobserver
(Cohen’s kappa ¼ 0.97, p < 0.001) variability for OCT
qualitative assessments of plaque components. OCT
morphological features and their distribution in symptom-
atic and asymptomatic patients are shown in Table 2 and
Figure 1. Symptomatic patients demonstrated higher rates of
complicated plaques compared with asymptomatic patients
(74.1% vs. 36.4%, respectively; p ¼ 0.02). These were largely
due to the higher incidence of TCFA with rupture (40.7%
vs. 13.6%, p ¼ 0.056) and thrombus (67.7% vs. 36.4%,
p ¼ 0.034); conversely, ﬁbrotic plaques were less commonly
identiﬁed in symptomatic versus asymptomatic patients
(18.5% vs. 59.1%, respectively; p ¼ 0.006). Macrophage
inﬁltration in the ﬁbrous cap was numerically more prevalent
in the symptomatic group, although differences were not
statistically signiﬁcant (37% vs. 22.7%, p ¼ 0.357). In
complicated plaques, all of the 7 calciﬁed nodules with
rupture and 12 of 14 (85.7%) of the ruptured TCFAs
identiﬁed had overlying intraluminal thrombus. In the
remaining 7 patients with demonstrated intraluminal
thrombus, there was no local source (i.e., plaque rupture)
documented by OCT analysis. By logistic regression anal-
ysis, intraluminal thrombus (odds ratio [OR]: 3.49, 95%
conﬁdence interval [CI]: 1.04 to 11.3, p ¼ 0.037) and
ruptured TCFA (OR: 4.35, 95% CI: 1.03 to 18.3, p ¼
0.045) were identiﬁed as independent predictors of symp-
tomatic status, whereas the presence of a ﬁbrotic plaque
(OR: 6.35, 95% CI: 1.74 to 23.0, p ¼ 0.005) predicted
asymptomatic status (Fig. 5). Although complicated features
were more prevalent in the symptomatic group, they were
evenly distributed in stenoses of <50% and >50% by OCT
analysis (Figs. 4 and 6).
Moreover, in 9 of 21 patients (42.8%) with plaque
rupture (TCFA or calciﬁed nodule), the site of rupture
was not located in the region of most critical stenosis
(median distance from minimal diameter site to plaque
Figure 2. Bland-Altman Plot of Angiographic and Optical Coherence Tomography Determination of NASCET Stenosis
Bland-Altman plot for optical coherence tomography and angiographically derived stenosis diameter is shown. Fourteen symptomatic patients had no
stenosis by either method. NASCET ¼ North American Symptomatic Carotid Endarterectomy Trial.
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679rupture ¼ 5.2 mm) (Fig. 6, Online Fig. 1). Sixty percent of
plaque ruptures were located proximal to and 40% were
located distal to the most critical stenosis site.
Discussion
The main ﬁndings of this study were the following:
1) Despite a good correlation between angiography andFigure 3. Discordant Angiographic Versus Optical Coherence Tomography Geome
A 70-year-old asymptomatic woman. Digital subtraction angiography (A, B) shows ex
the proximal internal carotid artery. Cross-section optical coherence tomography (O
(D) with an OCT-derived stenosis diameter of 74%. The corresponding locations of p
image (E). Duplex ultrasound demonstrated a peak systolic velocity of 229 cm/s witOCT for quantiﬁcation of carotid stenosis severity, angi-
ography failed to recognize important plaque features that
could potentially inﬂuence risk stratiﬁcation and treatment
strategy. 2) Complicated AHA type VI plaques were more
frequently demonstrated in symptomatic compared with
asymptomatic patients (higher rates of intraluminal
thrombus and ruptured TCFA were shown in the former),
but were also found in a large proportion of asymptomatictric Assessment
tensive calciﬁc plaque formation with 44% stenosis diameter (NASCET) involving
CT) images reveal a normal distal vessel (C) and an area of high-grade stenosis
anels C and D are shown with dashed circles (B) and in the longitudinal OCT
h an internal carotid/common carotid ratio of 5.1.
Figure 4. Smooth Nonobstructive Plaque With Type VI Features on Optical Coherence Tomography
A 78-year-old man with an acute left hemispheric stroke with symptom onset on the day before angiography. Diffusion-weighted magnetic resonance images
(A) reveal multiple small areas of restricted diffusion (dotted arrows) corresponding to acute ischemic insults. Digital subtraction catheter angiogram (B) reveals
smooth nonstenotic calciﬁed plaque at the internal carotid artery origin. (C, D) Optical coherence tomography images through the internal carotid artery origin reveal
calciﬁed plaque (red arrows) and intimal disruption (white arrowhead) with associated thrombus within (white arrow). The location corresponding to C is shown
as dashed circles in the catheter angiogram (B) and in the longitudinal OCT image (D).
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luminal thrombus were independent predictors of symp-
tomatic status. 4) In almost 43% of the patients, the site of
plaque rupture was not located in the most stenotic region.
5) No association between stenosis severity and the presence
of complicated plaque features was identiﬁed.
Despite data published in recent years linking the pres-
ence of complicated or vulnerable carotid plaque with stroke
and an awareness of the poor correlation between stenosis
severity and plaque risk proﬁle, current guidelines recom-
mend carotid artery revascularization exclusively on the basis
of angiography-derived stenosis severity. The AHA has
published an extensive histological classiﬁcation of athero-
sclerosis that includes a culprit complicated lesion (AHA
type VI plaque) (25) as deﬁned by intraplaque hemorrhage,
surface disruption, or intraluminal thrombosis. Although
this classiﬁcation scheme represents progress in the risk
stratiﬁcation of carotid artery disease, it is limited by its
reliance on pathological specimens or in vivo plaque
assessment with modalities that offer substantially lessresolution than OCT. The potential advantage of the
10-mm resolution of OCT is well documented with accurate
identiﬁcation of TCFA, vascular inﬂammation, intraluminal
thrombus, and plaque rupture (17–24), all important fea-
tures of plaque vulnerability.
Ischemic symptoms within the 6 months before presen-
tation were associated with complicated plaque in 74.1%
of patients. Importantly, these complicated plaque features
were seen in 36.4% of asymptomatic patients. Conversely,
uncomplicated (non–type VI features) plaques were more
common in asymptomatic than symptomatic patients
(63.6% vs. 25.9%). The preponderance of a complicated
plaque type in patients with symptomatic carotid artery
disease has been well documented in the pathology litera-
ture. Spangoli et al. (9) examined surgically removed plaques
from patients without symptoms versus those with transient
ischemic attack or stroke. After assessing endarterectomy
specimens in cohorts with similar degrees of angiographic
stenosis, the authors stressed that the presence and severity
of clinical events was signiﬁcantly correlated with thrombus
Figure 5. High-degree Stenosis With Non–Type VI Features on Optical Coherence Tomography
A 69-year-old asymptomatic woman. Moderate to severe stenosis in the internal carotid artery is demonstrated on the angiogram (A). Dashed circles in the
optical coherence tomography longitudinal view (B) correspond to the cross sections shown in C (normal vessel) and D (highly stenotic ﬁbrocalciﬁc plaque without
type VI features). CCA ¼ common carotid artery; ICA ¼ internal carotid artery.
Table 2. Plaque Morphology and Classiﬁcation in Symptomatic Versus
Asymptomatic Patients
Asymptomatic
(n ¼ 22)
Symptomatic
(n ¼ 27) p Value
Plaque morphology*
Fibrotic 13 (59.1) 5 (18.5) <0.01
Thrombus 8 (36.4) 18 (66.7) 0.03
Ruptured TCFA 3 (13.6) 11 (40.7) 0.06
Calciﬁed 7 (31.8) 2 (7.4) 0.06
Macrophage inﬁltration 5 (22.7) 10 (37.1) 0.36
Ruptured calciﬁed nodule 4 (18.2) 3 (11.1) 0.69
Nonruptured calciﬁed
nodule
3 (13.6) 4 (14.8) 1.00
Nonruptured TCFA 0 1 (3.7) 1.00
TCFA 3 (13.6) 3 (11.1) 1.00
AHA plaque type
VI 8 (36.4) 20 (74.1) 0.02
Non-VI 14 (63.6) 7 (25.9) 0.02
Values are n (%). *Plaques may contain >1 feature.
AHA ¼ American Heart Association; TCFA ¼ thick cap ﬁbroatheroma.
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681associated with plaque rupture. Clinical correlates with
multidetector computed tomography and MR imaging have
also demonstrated the etiological importance of plaque
morphology in the genesis of carotid artery related symp-
toms (8,10,11). In our series, we demonstrated higher rates
of ruptured TCFA and intraluminal thrombus in the carotid
vasculature of symptomatic compared with asymptomatic
patients. This group’s assessment of vulnerable plaque
notably eliminates the type VI criteria of intraplaque hem-
orrhage due to our inability to differentiate hemorrhage from
lipid pool with OCT, as both features lead to important
light attenuation, therefore impairing adequate evaluation.
Despite a relatively long mean interval between qualifying
symptoms and imaging and the practical elimination of 1
of the 3 validated features (intraplaque hemorrhage, cap
rupture, or intraluminal thrombus) of high-risk plaque in
our analysis, we were able to identify high-risk plaque in
nearly 75% of patients with symptomatic disease. We also
found higher rates, although not statistically signiﬁcant, of
macrophage inﬁltration in symptomatic patients.
Figure 6. Type VI Plaque Features Remote From Carotid Stenosis
A 59-year-old man with symptom onset 1 day before angiography. Digital subtraction angiography (A) shows a severe stenosis (dashed circle B) and extensive calciﬁc
plaque formation involving the proximal internal carotid artery (dashed circle C). Cross-section optical coherence tomography images reveal non–type VI features in
the area of high-grade stenosis (B). (C) Proximally, intimal disruption (arrow) consistent with type VI plaque is depicted in an area without luminal narrowing. The
corresponding locations of B and C are shown with dashed circles on the angiogram (A) and longitudinal optical coherence tomography image (D).
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682Last, this series shows no correlation between carotid
diameter stenosis and the presence of symptoms. Although
this conclusion may be biased because of the inclusion of
14 symptomatic patients who have no signiﬁcant carotid
narrowing, this lack of correlation persists even after the
exclusion of this group (p ¼ 0.10 for all patients, p ¼ 0.33
after exclusion of subjects with no stenosis). Although at
odds with some natural history studies (31), this ﬁnding is
consistent with the major asymptomatic carotid endarter-
ectomy trials in which there was no association between risk
of stroke and a stenosis diameter between 60% and 99%
(5,6), further arguing for the relevance of plaque character-
istics in an assessment of stroke risk.
The present study ﬁndings are important in several
respects. First, it is the only observational study to date
that explores the morphological differences between
recently symptomatic and asymptomatic carotid plaque
using OCT. Second, the study suggests that the describedtechnique, by offering the highest image resolution of any
intravascular imaging technique available, even without any
special technique accommodation for balloon occlusion or,
in some cases, contrast use (26), can reliably and safely
identify complicated or vulnerable plaque in the carotid
arteries.
The high accuracy and reproducibility of OCT for the
assessment of lumen dimensions has been previously docu-
mented (15). The present study, moreover, although
demonstrating good correlation and agreement between
OCT- and angiography-derived luminal measurements,
documents enough “scatter” of data points to warrant a
change in revascularization recommendations in 40% of
patients on the basis of OCT versus planar determination
(29% treatment deferred, 11% treatment recommended), as
a result of the more accurate 3-dimensional data acquired
by OCT. Most importantly, in the group studied, asymp-
tomatic patients actually exhibited greater stenosis compared
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683with symptomatic patients; in addition, there was no associ-
ation between carotid stenosis (angiography- or OCT-
derived) and plaque morphology. As a result, in this series,
plaque characteristics rather than carotid diameter stenosis
were correlated with ischemic symptoms.
Safety issues. Carotid artery instrumentation may carry a
risk of embolization or vascular complications. Indeed, 1
patient in this case series had a minor guiding catheter–
related carotid dissection that was unassociated with clinical
sequelae. No other complications were noted. At this time,
the additive risk of carotid OCT to carotid angiography and
stent procedures is uncertain as this safety endpoint has not
been studied is appropriately powered trials. The CAPITAL
(Carotid Artery Plaque Virtual Histology Evaluation) trial
(32) and other small case series (12,33) report no such issues
with intravascular ultrasound, a technique analogous to
OCT; however, only small case series are available for
review. Similarly, very small series of patients undergoing
carotid OCT both with and without balloon occlusion
(14,34–38) report only a single complication that was
thought to be related to balloon occlusion. Intuitively, our
group believed that the placement of an OCT catheter
across a carotid plaque should pose no more risk than the
deployment and retrieval of an embolic protection device.
This was on the basis of our clinical concern of the potential
risk of embolization after the deployment and capture of a
5.2-French embolic protection device versus a 2.7-French
OCT catheter. It is therefore noted that this group did
not use distal embolic protection devices in patients under-
going study unless an intervention was planned. Deﬁnitive
assessment of the safety of intravascular imaging devices in
the carotid arteries awaits the publication of larger, appro-
priately powered trials.
Study limitations. The case series reported involves a single-
center retrospective analysis of nonrandomized cases; in
addition, 14 of the symptomatic patients were studied because
of the absence of an obvious source of stroke or signiﬁcant
stenosis on angiography. Patients were considered symp-
tomatic if symptoms pre-dated the study for as long as 6
months. Any of these factors could have inﬂuenced the re-
ported ﬁndings. It should as well be noted that the use of
OCT-derived data to facilitate patient management was done
empirically as no large studies validating the clinical use of
carotid OCT are available; nevertheless, this was a pilot
study, and our ﬁndings allowed great insights into plaque
morphology of carotid atherosclerosis. It is also noted that
we assumed that OCT histopathological correlations that
have been extensively validated outside of the carotid circu-
lation are also valid in the carotid vasculature. Finally,
although contralateral carotid OCT assessment would have
been interesting as a “control” OCT reference, the retro-
spective nature of our analysis coupled with the undeﬁned
safety risks of bilateral versus unilateral studies precluded such
assessments.Conclusions
This retrospective analysis of carotid artery OCT data
suggests that there is a potential for this high-resolution
imaging modality to facilitate our understanding of carotid
artery disease in several respects. First, the edge detection
offered by this high-resolution technique promises an
advantage in the assessment of carotid geometry over the
lower resolution MR data and indirect (i.e., velocity
dependent) carotid duplex studies. Second although both
MR and duplex plaque characterization have been studied in
reference to their potential to detect complicated plaque,
the much higher resolution of OCT promises to be a gold
standard by which noninvasive studies could be compared.
Last, there may as well be a future potential for OCT to
assess carotid stent-vessel interactions (14,38) and compli-
cations during carotid stent procedures, noting that nonin-
vasive modalities will not be useful in this regard due to
stent interference with the acquisition of images. We do
acknowledge that this small observational study is not suf-
ﬁcient to suggest a change in treatment strategies, but that
further large-scale prospective trials will be required to assess
the role of OCT imaging in the evaluation and treatment of
carotid artery disease.
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